Real-world impact of nirsevimab immunisation and maternal RSV vaccination against respiratory disease on emergency department attendances and admissions: a multinational retrospective analysis

Key Points

• Emergency department attendances were significantly reduced following nirsevimab immunisation, suggesting its effectiveness.
• Maternal vaccination against RSV showed a notable decrease in subsequent respiratory disease admissions, highlighting its protective benefits.
• Retrospective analysis across multiple countries provides insights into the real-world impact of these interventions on healthcare usage.
• Findings emphasize the need for continued evaluation of vaccination strategies to mitigate RSV-related health issues.